Literature DB >> 6477222

Neuromyelitis optica with unusual vascular changes.

D Lefkowitz, J N Angelo.   

Abstract

A case of neuromyelitis optica had strikingly increased numbers of thickened, hyalinized small blood vessels, which were associated with cystic degeneration in the cervical spinal cord and the optic chiasm. These findings support the contention that neuromyelitis optica is a clinical syndrome rather than a distinct nosologic entity.

Entities:  

Mesh：

Year:  1984        PMID： 6477222     DOI： 10.1001/archneur.1984.04050210105027

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


  11 in total

1.  Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica.

Authors:  C S Yu; F C Lin; K C Li; T Z Jiang; C Z Zhu; W Qin; H Sun; P Chan
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

2.  Neuromyelitis optica (Devic's syndrome): no association with the primary mitochondrial DNA mutations found in Leber hereditary optic neuropathy.

Authors:  H Cock; R Mandler; W Ahmed; A H Schapira
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

3.  Disseminated cholesterol embolism presenting as neuromyelitis optica.

Authors:  M Goldman; F Rickaert; P Voordecker; S Goldman; J Flament-Durand
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-19

4.  Prediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)-6 produced during remission phase.

Authors:  P O Barros; T Cassano; J Hygino; T B Ferreira; N Centurião; T M Kasahara; R M Andrade; U C Linhares; A F B Andrade; C C F Vasconcelos; R Alvarenga; R Marignier; C A M Bento
Journal:  Clin Exp Immunol       Date:  2015-12-01       Impact factor: 4.330

5.  Neuromyelitis optica in the old age: a clinico-pathological contribution.

Authors:  M Ghezzi; M Giansanti; G M Malentacchi; F Barontini
Journal:  Ital J Neurol Sci       Date:  1987-12

6.  The ex vivo production of IL-6 and IL-21 by CD4+ T cells is directly associated with neurological disability in neuromyelitis optica patients.

Authors:  Ulisses C Linhares; Patrícia B Schiavoni; Priscila O Barros; Taissa M Kasahara; Bruna Teixeira; Thais B Ferreira; Regina Alvarenga; Joana Hygino; Morgana M M Vieira; Vera Carolina B Bittencourt; Regis M Andrade; Arnaldo F Andrade; Cleonice A M Bento
Journal:  J Clin Immunol       Date:  2012-09-05       Impact factor: 8.317

7.  Idiopathic transverse myelitis and neuromyelitis optica: clinical profiles, pathophysiology and therapeutic choices.

Authors:  Amer Awad; Olaf Stüve
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

Review 8.  Immunotherapy of neuromyelitis optica.

Authors:  Benjamin Bienia; Roumen Balabanov
Journal:  Autoimmune Dis       Date:  2013-12-25

9.  Initial Pattern of Optic Nerve Enhancement in Korean Patients with Unilateral Optic Neuritis.

Authors:  Dae Yong Son; Kyung-Ah Park; Su Sie Seok; Ju-Yeun Lee; Sei Yeul Oh
Journal:  Korean J Ophthalmol       Date:  2017-02-02

10.  Comparison of macular structural and vascular changes in neuromyelitis optica spectrum disorder and primary open angle glaucoma: a cross-sectional study.

Authors:  Xiayin Zhang; Hui Xiao; Chunxin Liu; Lanqin Zhao; Jinghui Wang; Haiquan Li; Ruixin Wang; Yi Zhu; Chuan Chen; Xiaohang Wu; Duoru Lin; Jingqi Wang; Xing Liu; Wei Qiu; Patrick Yu-Wai-Man; Daniel S Ting; Haotian Lin
Journal:  Br J Ophthalmol       Date:  2020-05-19       Impact factor: 4.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.